$54.80
1.92[3.63%]
At close: Apr 26
$54.80
0[0.00%]
After Hours: 4:16PM EDT
Praxis Precision Medicine
(NASDAQ:PRAX)Praxis Precision Medicine Stock (NASDAQ:PRAX), Analyst Ratings, Price Targets, Predictions
Praxis Precision Medicines Inc has a consensus price target of $62, established from looking at the 27 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Jefferies, and HC Wainwright & Co. on April 26, 2024, March 26, 2024, and March 26, 2024. With an average price target of $112.67 between HC Wainwright & Co., Jefferies, and HC Wainwright & Co., there's an implied 105.60% upside for Praxis Precision Medicines Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Jefferies
Wedbush
Truist Securities
William Blair
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Praxis Precision Medicine
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/26/2024 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | 91.61% | HC Wainwright & Co. | Douglas Tsao | → $105 | Reiterates | Buy → Buy | Get Alert |
| 03/26/2024 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | 133.58% | Jefferies | Kambiz Yazdi | $75 → $128 | Maintains | Buy | Get Alert |
| 03/26/2024 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | 91.61% | HC Wainwright & Co. | Douglas Tsao | → $105 | Reiterates | Buy → Buy | Get Alert |
| 03/06/2024 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | 91.61% | HC Wainwright & Co. | Douglas Tsao | → $105 | Reiterates | Buy → Buy | Get Alert |
| 01/12/2024 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | -47.08% | Wedbush | Laura Chico | $16 → $29 | Maintains | Neutral | Get Alert |
| 12/05/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | 91.61% | HC Wainwright & Co. | Douglas Tsao | → $105 | Reiterates | Buy → Buy | Get Alert |
| 12/04/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | 173.72% | Truist Securities | Joon Lee | → $150 | Reiterates | Buy → Buy | Get Alert |
| 11/15/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | -87.23% | HC Wainwright & Co. | Douglas Tsao | → $105 | Reiterates | Buy → Buy | Get Alert |
| 10/03/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | -96.35% | Wedbush | Laura Chico | → $30 | Reiterates | Neutral → Neutral | Get Alert |
| 09/19/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | -81.75% | Truist Securities | Joon Lee | → $150 | Initiates | → Buy | Get Alert |
| 08/10/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | -87.23% | HC Wainwright & Co. | Douglas Tsao | $225 → $105 | Maintains | Buy | Get Alert |
| 08/09/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | -72.63% | HC Wainwright & Co. | Douglas Tsao | → $225 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | -96.35% | Wedbush | Laura Chico | → $30 | Reiterates | Neutral → Neutral | Get Alert |
| 06/12/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | -72.63% | HC Wainwright & Co. | Douglas Tsao | → $225 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | -92.7% | Jefferies | Kambiz Yazdi | → $60 | Initiates | → Buy | Get Alert |
| 05/12/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | -96.35% | Wedbush | Laura Chico | → $30 | Reiterates | → Neutral | Get Alert |
| 05/12/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | -72.63% | HC Wainwright & Co. | Douglas Tsao | → $225 | Reiterates | Buy → Buy | Get Alert |
| 04/14/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | -70.8% | HC Wainwright & Co. | Douglas Tsao | → $240 | Reiterates | → Buy | Get Alert |
| 03/06/2023 | PRAX | Buy Now | Praxis Precision Medicine | $54.80 | — | William Blair | Myles Minter | — | Downgrade | Outperform → Market Perform | Get Alert |
FAQ
What is the target price for Praxis Precision Medicine (PRAX)?
The latest price target for Praxis Precision Medicine (NASDAQ: PRAX) was reported by HC Wainwright & Co. on April 26, 2024. The analyst firm set a price target for $105.00 expecting PRAX to rise to within 12 months (a possible 91.61% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Praxis Precision Medicine (PRAX)?
The latest analyst rating for Praxis Precision Medicine (NASDAQ: PRAX) was provided by HC Wainwright & Co., and Praxis Precision Medicine reiterated their buy rating.
When was the last upgrade for Praxis Precision Medicine (PRAX)?
There is no last upgrade for Praxis Precision Medicine.
When was the last downgrade for Praxis Precision Medicine (PRAX)?
The last downgrade for Praxis Precision Medicines Inc happened on March 6, 2023 when William Blair changed their price target from N/A to N/A for Praxis Precision Medicines Inc.
When is the next analyst rating going to be posted or updated for Praxis Precision Medicine (PRAX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Praxis Precision Medicine, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Praxis Precision Medicine was filed on April 26, 2024 so you should expect the next rating to be made available sometime around April 26, 2025.
Is the Analyst Rating Praxis Precision Medicine (PRAX) correct?
While ratings are subjective and will change, the latest Praxis Precision Medicine (PRAX) rating was a reiterated with a price target of $0.00 to $105.00. The current price Praxis Precision Medicine (PRAX) is trading at is $54.80, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.